- Home
- CYTK vs NXST Comparison
CYTK vs NXST Comparison
Compare CYTK & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- NXST
- Stock Information
- Founded
- CYTK 1997
- NXST 1996
- Country
- CYTK United States
- NXST United States
- Employees
- CYTK N/A
- NXST N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- NXST Broadcasting
- Sector
- CYTK Health Care
- NXST Industrials
- Exchange
- CYTK Nasdaq
- NXST Nasdaq
- Market Cap
- CYTK 6.0B
- NXST 5.7B
- IPO Year
- CYTK 2004
- NXST 2003
- Fundamental
- Price
- CYTK $49.10
- NXST $169.75
- Analyst Decision
- CYTK Buy
- NXST Strong Buy
- Analyst Count
- CYTK 16
- NXST 7
- Target Price
- CYTK $83.67
- NXST $199.71
- AVG Volume (30 Days)
- CYTK 1.4M
- NXST 407.3K
- Earning Date
- CYTK 11-06-2024
- NXST 11-07-2024
- Dividend Yield
- CYTK N/A
- NXST 3.98%
- EPS Growth
- CYTK N/A
- NXST 46.23
- EPS
- CYTK N/A
- NXST 17.25
- Revenue
- CYTK $3,219,000.00
- NXST $5,224,000,000.00
- Revenue This Year
- CYTK N/A
- NXST $14.01
- Revenue Next Year
- CYTK $911.39
- NXST N/A
- P/E Ratio
- CYTK N/A
- NXST $9.84
- Revenue Growth
- CYTK N/A
- NXST 2.11
- 52 Week Low
- CYTK $30.68
- NXST $141.38
- 52 Week High
- CYTK $110.25
- NXST $191.86
- Technical
- Relative Strength Index (RSI)
- CYTK 39.46
- NXST 50.43
- Support Level
- CYTK $49.64
- NXST $159.11
- Resistance Level
- CYTK $59.39
- NXST $191.86
- Average True Range (ATR)
- CYTK 2.46
- NXST 5.93
- MACD
- CYTK -0.69
- NXST -0.57
- Stochastic Oscillator
- CYTK 14.11
- NXST 32.49
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About NXST Nexstar Media Group Inc.
Nexstar Media Group Inc is the largest television station owner-operator in the United States with over 200 stations in 116 markets. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. The 2019 merger with Tribune made Nexstar the top broadcast affiliate for both Fox and CBS as well as the number-two partner for NBC and number three for ABC. The firm has stations in 12 of the top 20 television markets and reaches 68% of us TV households. Nexstar also owns NewsNation (formerly WGN), a nationwide pay-television network, 75% of The CW, and a 31% stake in Food Network and Cooking Channel.